Morphine Consumption in Thoracotomy

Sponsor
Kocaeli University (Other)
Overall Status
Completed
CT.gov ID
NCT04999319
Collaborator
(none)
44
1
2
15.3
2.9

Study Details

Study Description

Brief Summary

Importance of effective postoperative pain management is well known. The undesired effects of pain can be prevented with multimodal analgesia for the patient. Thoracotomy operations are associated with high levels of pain. With the use of ultrasound, many regional anesthesia techniques were described to provide effective postoperative analgesia. The aim of this study was to compare the postoperative effect of paravertebral block (PVB) and erector spinal plane block (ESPB) in thoracotomies.

Condition or Disease Intervention/Treatment Phase
  • Procedure: PVB
  • Procedure: ESPB
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
44 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Comparison of Morphine Consumption at Postoperative 24th Hour in Thoracotomy: A Randomized Controlled Trial
Actual Study Start Date :
Oct 15, 2020
Actual Primary Completion Date :
Jan 5, 2022
Actual Study Completion Date :
Jan 25, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: PVB Group

Paravertebral block administered group

Procedure: PVB
Paravertebral block will be performed before the surgery with 20 mL of %0.5 bupivacaine at T4 level.

Active Comparator: ESPB group

Erector spinae plane block administered group

Procedure: ESPB
Erector spinae plane block will be performed before the surgery with 20 mL of %0.5 bupivacaine at T4 level.

Outcome Measures

Primary Outcome Measures

  1. Morphine consumption [Postoperative 24th hour]

    Morphine consumption (mg) of patients with patient controlled analgesia device

  2. NRS score [Postoperative 24th hour]

    Numerating rating scale of the patients (between 0 and 10, 0 represents no pain and 10 represents the worst pain ever possible.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ASA I-III patients undergo elective thoracotomy surgeries.
Exclusion Criteria:
  • Obesity (BMI > 35 kg/m2)

  • Infection of the skin at the site of the needle puncture area

  • Patients with known allergies to any of the study drugs

  • Coagulopathy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kocaeli Unversity Kocaeli Turkey

Sponsors and Collaborators

  • Kocaeli University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mustafa Duran, MD, Principal investigator., Kocaeli University
ClinicalTrials.gov Identifier:
NCT04999319
Other Study ID Numbers:
  • GOKAEK-2020/18.09
First Posted:
Aug 10, 2021
Last Update Posted:
Jan 26, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mustafa Duran, MD, Principal investigator., Kocaeli University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2022